| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $307.2M | +0.2% |
| Cost of Revenue | $187.8M | +3.7% |
| Gross Profit | $119.4M | -4.9% |
| R&D Expense | $20.8M | +4.3% |
| SG&A Expense | $109.6M | +2.0% |
| Operating Income | $13.8M | -17.9% |
| Pre-tax Income | $8.8M | -49.9% |
| Income Tax | $3.5M | -55.3% |
| Net Income | $5.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.4M | +10.2% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $56.3M | +10.1% |
| Inventory | $82.8M | -1.6% |
| Current Assets | $247.0M | +4.2% |
| Total Assets | $455.9M | +1.1% |
| Current Liabilities | $55.3M | +4.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.4M | -27.4% |
| Investing Cash Flow | $2.9M | +122.5% |
| Financing Cash Flow | -$11.4M | -21.3% |
| -46.6% |
| EPS (Basic) | $0.40 | -45.9% |
| EPS (Diluted) | $0.40 | -45.9% |
| Long-term Debt |
| $20.6M |
| -34.5% |
| Total Liabilities | $119.7M | -7.3% |
| Stockholders' Equity | $336.4M | +4.5% |